We are live on ! Find out more
Bill Ackman

Bill Ackman Pershing Square Capital Management

AUM $13.7B
1-Year Est. Return 13.45%
 

Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.

This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+13.45%
3 Year Est. Return
+64.66%
5 Year Est. Return
+90.44%
10 Year Est. Return
+446.13%
AUM
$15B
AUM Growth
-$1.07B
Cap. Flow
-$1.81B
Cap. Flow %
-12.1%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$3.45B
2
AGN
Allergan plc
AGN
+$384M
3
ZTS icon
Zoetis
ZTS
+$11.4M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$5.66B

Sector Composition

Rank Sector Weight
1 Healthcare 41.45%
2 Materials 28.09%
3 Industrials 17.01%
4 Consumer Discretionary 9.75%
5 Real Estate 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
1
Bausch Health
BHC
$2.33B
$3.87B 25.84%
+19,473,933
New +$3.45B
APD icon
2
Air Products & Chemicals
APD
$68.9B
$3.11B 20.77%
22,213,551
– –
CP icon
3
Canadian Pacific Kansas City
CP
$80.8B
$2.55B 17.01%
69,704,450
– –
ZTS icon
4
Zoetis
ZTS
$31.1B
$1.94B 12.93%
41,823,145
+253,499
+0.6% +$11.4M
QSR icon
5
Restaurant Brands International
QSR
$25.6B
$1.46B 9.75%
38,003,984
– –
ESI icon
6
Element Solutions
ESI
$9.17B
$1.1B 7.33%
42,737,394
– –
HHH icon
7
Howard Hughes
HHH
$4B
$553M 3.69%
3,742,850
– –
AGN
8
DELISTED
Allergan plc
AGN
$401M 2.68%
+1,348,358
New +$384M
AGN
9
DELISTED
Allergan Inc
AGN
– –
-26,635,978
Closed -$5.66B

Similar funds

WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $13.5B AUM 15.15% 1-Year Est. Return

Bill Ackman's Q1 2015 Portfolio in Review

As of Q1 2015, Bill Ackman held 9 positions worth $15B, down 6.7% from $16B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bill Ackman withdrew a net $1.81B in Q1 2015, closing 1 position. Its most notable exit was Allergan Inc, an estimated $5.66B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Materials and Industrials.

Against the trend, Bill Ackman opened a new position in Bausch Health worth $3.87B.

  • Bill Ackman's largest Q1 2015 buy was Bausch Health: 19,473,933 shares worth $3.87B.
  • Bill Ackman added most to Zoetis in Q1 2015, an estimated $11.4M increase.
  • Bill Ackman fully exited Allergan Inc in Q1 2015, selling an estimated $5.66B.
  • Bill Ackman's ten largest holdings make up 100% of its $15B portfolio in Q1 2015.
  • Bill Ackman opened 2 new positions and closed 1 in Q1 2015.
  • Bill Ackman's portfolio value fell 6.7% quarter-over-quarter to $15B.

Based on Pershing Square Capital Management's 13F filing for Q1 2015, filed 15 May 2015.